Promis Neurosciences Inc. (PMN) SEC Filings — 2025

Filings

• ProMIS Neurosciences Inc. Files 8-K — 8-K · Dec 16, 2025
• ProMIS Neurosciences Files 8-K — 8-K · Nov 24, 2025
• ProMIS Neurosciences Files 8-K on Shareholder Vote Matters — 8-K · Nov 19, 2025
• ProMIS Neurosciences R&D Soars, Net Loss Widens to $29M — 10-Q · Nov 12, 2025
• ProMIS Neurosciences Announces Board and Officer Changes — 8-K · Oct 24, 2025
• ProMIS Neurosciences Seeks Shareholder Nod for 1:5 to 1:25 Reverse Split — DEF 14A · Oct 3, 2025
• ProMIS Neurosciences Announces Board and Executive Changes — 8-K · Sep 30, 2025
• ProMIS Neurosciences Files 8-K — 8-K · Sep 3, 2025
• ProMIS Neurosciences Enters Material Definitive Agreement — 8-K · Aug 19, 2025
• ProMIS Neurosciences' Losses Mount Amid Soaring R&D Costs — 10-Q · Aug 13, 2025
• ProMIS Neurosciences Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 28, 2025
• ProMIS Neurosciences Enters Material Definitive Agreement — 8-K · Jul 22, 2025
• Sun Pharma to Acquire ProMIS Neurosciences for $117M — 8-K · Jul 7, 2025
• ProMIS Neurosciences Files 8-K on Board Changes and Votes — 8-K · Jun 13, 2025
• ProMIS Neurosciences Files Q1 2025 10-Q — 10-Q · May 12, 2025
• ProMIS Neurosciences Files 2025 Proxy Statement — DEF 14A · Apr 29, 2025
• ProMIS Neurosciences Files 2024 Annual Report — 10-K · Mar 31, 2025
• ProMIS Neurosciences Files 8-K — 8-K · Feb 25, 2025
• ProMIS Neurosciences Announces Board and Executive Changes — 8-K · Feb 19, 2025
• ProMIS Neurosciences Files 8-K — 8-K · Jan 27, 2025
• ProMIS Neurosciences Files 8-K — 8-K · Jan 10, 2025
• ProMIS Neurosciences Faces Delisting Concerns — 8-K · Jan 8, 2025